Quantcast

Latest Arlington Medical Resources Stories

2010-12-15 07:00:00

MALVERN, Pa., Dec. 15, 2010 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that, in the treatment of atrial fibrillation, surveyed European cardiologists indicate that use of vitamin K antagonists, as a class, is primarily driven by the availability of an oral formulation, overall low cost and widespread inclusion on European medical society guidelines and hospital formularies....

2010-12-02 09:00:00

MALVERN, Pa., Dec. 2, 2010 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds surveyed internal medicine physicians cite that the most important factors influencing hospital selection of antibiotics used for inpatient community-acquired pneumonia (CAP) are recommendations from medical society guidelines (e.g. American Thoracic Society guidelines on pneumonia) and recommendations from...

2010-11-02 08:17:00

MALVERN, Pa., Nov. 2, 2010 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that the leading driver of antibiotic selection in nosocomial pneumonia in the United States is activity against key drug-resistant pathogens. Such pathogens include P. aeruginosa, MRSA, Vancomycin-resistant Staphylococcus aureus and multidrug-resistant Steptococcus pneumonia. "Nosocomial pneumonia is one of...

2010-10-06 08:00:00

MALVERN, Pa., Oct. 6 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that methicillin-resistant Staphylococcus aureus (MRSA) is the most concerning pathogen to surveyed U.S. physicians with regard to their treatment of skin and skin structure infections. A drug's activity against MRSA is among the top factors that influences U.S. physician drug selection for treating skin and skin...

2010-09-28 08:30:00

MALVERN, Pa., Sept. 28 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that more than half of all European inpatients who receive anticoagulants during their hospital stay are administered Sanofi-Aventis's Clexane (marketed as Lovenox in the U.S. and France). The new audit entitled The European Hospital Anticoagulant Market Guide is a comprehensive source for anticoagulant use in...

2010-06-22 07:00:00

MALVERN, Pa., June 22 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that surveyed infectious disease specialists anticipate changes in their future prescribing patterns for treating hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections. Physicians want to continue gaining experience with currently branded anti-infectives such as Cubist's Cubicin,...

2010-06-14 07:00:00

MALVERN, Pa., June 14 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that electrical cardioversion (ECV) usage patterns in Europe differed dramatically by country in the fourth quarter of 2009. While ECV represented almost half of all cardioversion attempts in Germany, in Spain ECV accounted for only 13% of cardioversion attempts. Among the five countries studied, cardioversion...

2010-05-17 07:00:00

MALVERN, Pa., May 17 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that surveyed clinicians cite extended-spectrum beta-lactamase (ESBL)-producing E. coli and K. pneumoniae as the most concerning resistant pathogens in hospital-acquired gram-negative infections. These pathogens are resistant to commonly prescribed first-line antibiotics (e.g., penicillins, cephalosporins), and...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related